• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续皮下胰岛素输注治疗的糖尿病患者中显著“黎明现象”的罕见性。

Rarity of a marked "dawn phenomenon" in diabetic subjects treated by continuous subcutaneous insulin infusion.

作者信息

Bending J J, Pickup J C, Collins A C, Keen H

出版信息

Diabetes Care. 1985 Jan-Feb;8(1):28-33. doi: 10.2337/diacare.8.1.28.

DOI:10.2337/diacare.8.1.28
PMID:3971844
Abstract

We assessed the quality of overnight glycemic control and the frequency of the "dawn phenomenon" (nadir-0800 h glycemic increase) in 41 insulin-dependent diabetic patients treated by continuous subcutaneous insulin infusion (CSII). Mean plasma glucose levels were near-normal during the 24 h and, in particular, constant throughout the night. In a subset of six patients overnight plasma free insulin concentrations were also constant during CSII. The majority of profiles (88%) showed a glucose nadir from 2.0 to 5.9 mmol/L (most frequently at 0600 h) and had an 0800 h value from 2.0 to 6.9 mmol/L (92%). A large proportion (46%) of profiles showed a zero or negative nadir-0800 h glycemic increase. In 22 patients with three or more profiles recorded at the same basal insulin infusion rate, only one of 103 profiles had a fasting glycemic increase greater than an arbitrary value of 5.0 mmol/L (5.3), although many patients exhibited small dawn glycemic increases (e.g., 14 of 22 had a mean increase of from 0 to 2 mmol/L). In 12 subjects a 15% reduction in basal insulin infusion rate increased the mean +/- SEM dawn glycemic increase from 0.58 +/- 0.25 mmol/L to 2.7 +/- 0.76 mmol/L (P less than 0.025) as well as significantly increasing the nocturnal nadir and 0800 h plasma glucose concentrations. Thus, a marked dawn phenomenon is rare when a single but adequate basal infusion rate is used for CSII, and this questions the need in the majority of patients for preprogrammable pumps with nocturnal infusion rate changes.

摘要

我们评估了41例接受持续皮下胰岛素输注(CSII)治疗的胰岛素依赖型糖尿病患者夜间血糖控制质量及“黎明现象”(最低点至08:00时血糖升高)的发生频率。24小时内平均血浆葡萄糖水平接近正常,尤其是整个夜间保持稳定。在6例患者的亚组中,CSII期间夜间血浆游离胰岛素浓度也保持稳定。大多数血糖曲线(88%)显示血糖最低点在2.0至5.9 mmol/L之间(最常见于06:00时),08:00时血糖值在2.0至6.9 mmol/L之间(92%)。很大一部分(46%)血糖曲线显示最低点至08:00时血糖升高为零或呈负值。在22例以相同基础胰岛素输注速率记录了三条或更多血糖曲线的患者中,103条曲线中只有1条空腹血糖升高大于任意设定值5.0 mmol/L(5.3),尽管许多患者表现出较小的黎明血糖升高(例如,22例中有14例平均升高0至2 mmol/L)。在另外12例受试者中,基础胰岛素输注速率降低15%,使平均±标准误黎明血糖升高从0.58±0.25 mmol/L增至2.7±0.76 mmol/L(P<0.025),同时显著增加了夜间最低点及08:00时血浆葡萄糖浓度。因此,当CSII使用单一且合适的基础输注速率时,明显的黎明现象很少见,这对大多数患者是否需要可预设夜间输注速率变化的胰岛素泵提出了质疑。

相似文献

1
Rarity of a marked "dawn phenomenon" in diabetic subjects treated by continuous subcutaneous insulin infusion.持续皮下胰岛素输注治疗的糖尿病患者中显著“黎明现象”的罕见性。
Diabetes Care. 1985 Jan-Feb;8(1):28-33. doi: 10.2337/diacare.8.1.28.
2
Twenty-Four Hour Fasting (Basal Rate) Tests to Achieve Custom-Tailored, Hour-by-Hour Basal Insulin Infusion Rates in Patients With Type 1 Diabetes Using Insulin Pumps (CSII).24 小时禁食(基础率)测试,以实现使用胰岛素泵(CSII)的 1 型糖尿病患者的个性化、逐小时基础胰岛素输注率
J Diabetes Sci Technol. 2021 Mar;15(2):360-370. doi: 10.1177/1932296819882752. Epub 2019 Oct 21.
3
Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII.持续皮下胰岛素输注治疗的糖尿病患者黎明现象的发病机制与预防
Diabetes. 1986 Jan;35(1):78-82. doi: 10.2337/diab.35.1.78.
4
The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus.无症状性夜间低血糖对糖尿病患者血糖控制的影响。
N Engl J Med. 1988 Nov 10;319(19):1233-9. doi: 10.1056/NEJM198811103191901.
5
Patients with Type 1 Diabetes Treated with Insulin Pumps Need Widely Heterogeneous Basal Rate Profiles Ranging from Negligible to Pronounced Diurnal Variability.使用胰岛素泵治疗的 1 型糖尿病患者需要广泛的基础率谱,从微不足道到明显的日间变化不等。
J Diabetes Sci Technol. 2021 Nov;15(6):1262-1272. doi: 10.1177/1932296820949939. Epub 2020 Aug 18.
6
Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.斋月禁食期间1型糖尿病患者胰岛素泵治疗与多次皮下注射胰岛素方案的比较
Diabetes Technol Ther. 2017 Jun;19(6):349-354. doi: 10.1089/dia.2016.0418. Epub 2017 Mar 15.
7
Nocturnal blood glucose control in type I diabetes mellitus.1型糖尿病的夜间血糖控制
Diabetes Care. 1993 Dec;16 Suppl 3:71-89. doi: 10.2337/diacare.16.3.71.
8
Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.在1型糖尿病患者中,使用持续皮下胰岛素输注时,使用速效门冬胰岛素可改善餐后血糖控制。
Diabetes Technol Ther. 2017 Jan;19(1):25-33. doi: 10.1089/dia.2016.0350. Epub 2017 Jan 5.
9
Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.25岁时的持续皮下胰岛素输注:1型糖尿病中胰岛素泵治疗应用不断扩大的证据基础
Diabetes Care. 2002 Mar;25(3):593-8. doi: 10.2337/diacare.25.3.593.
10
Early-morning hyperglycemia in diabetic individuals treated with continuous subcutaneous insulin infusion.
Diabetes Care. 1983 Mar-Apr;6(2):135-9. doi: 10.2337/diacare.6.2.135.

引用本文的文献

1
Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems.三种先进混合闭环系统对1型糖尿病成人患者实现血糖目标的夜间有效性比较。
Acta Diabetol. 2024 Nov 22. doi: 10.1007/s00592-024-02397-9.
2
Insulin Titration Guidelines for Patients With Type 1 Diabetes: It Is About Time!1 型糖尿病患者胰岛素滴定指南:是时候了!
J Diabetes Sci Technol. 2023 Jul;17(4):1066-1076. doi: 10.1177/19322968221087261. Epub 2022 Apr 2.
3
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes.
关于黎明现象的三十年研究:优化糖尿病血糖控制的经验教训
Diabetes Care. 2013 Dec;36(12):3860-2. doi: 10.2337/dc13-2088.
4
Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.1型糖尿病中多次皮下注射胰岛素方案(基础胰岛素每日一次甘精胰岛素加餐时胰岛素赖脯胰岛素)与持续皮下胰岛素输注(胰岛素赖脯胰岛素)的比较:一项随机开放平行多中心研究。
Diabetes Care. 2009 Jul;32(7):1170-6. doi: 10.2337/dc08-1874. Epub 2009 Apr 23.
5
Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans.低血糖后高酮血症在人类胰岛素诱导的低血糖期间对脑代谢无贡献。
Diabetologia. 1993 Nov;36(11):1191-7. doi: 10.1007/BF00401065.
6
Early posthypoglycemic insulin resistance in man is mainly an effect of beta-adrenergic stimulation.人体低血糖后早期胰岛素抵抗主要是β-肾上腺素能刺激的结果。
J Clin Invest. 1987 Aug;80(2):437-42. doi: 10.1172/JCI113091.
7
Insulin resistance in type 1 (insulin-dependent) diabetes following hypoglycaemia--evidence for the importance of beta-adrenergic stimulation.1型(胰岛素依赖型)糖尿病低血糖后的胰岛素抵抗——β-肾上腺素能刺激重要性的证据
Diabetologia. 1987 Sep;30(9):691-7. doi: 10.1007/BF00296990.
8
Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.
Diabetologia. 1990 Jan;33(1):52-9. doi: 10.1007/BF00586461.
9
The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity.1型(胰岛素依赖型)糖尿病中的黎明现象:程度、频率、变异性以及对葡萄糖对抗调节和胰岛素敏感性的依赖性。
Diabetologia. 1991 Jan;34(1):21-8. doi: 10.1007/BF00404020.
10
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis.肾上腺素能机制通过刺激脂肪分解,在人类低血糖葡萄糖反调节的后期发挥作用。
J Clin Invest. 1992 Jun;89(6):2005-13. doi: 10.1172/JCI115809.